Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
5
83%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

unknown233%
terminated117%
completed350%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

ADAM17 and Vascular Function in Diabetes

NCT04557228
completednot_applicable

The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years

NCT05177978
unknownnot_applicable

Phosphatidylserine Improves Cognitive Function in the Elderly

NCT04920305
unknownnot_applicable

The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists

NCT04967404
completedphase_2

The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia

NCT02276716
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04557228Not Applicable

ADAM17 and Vascular Function in Diabetes

Completed
NCT05177978Not Applicable

The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years

Completed
NCT04920305Not Applicable

Phosphatidylserine Improves Cognitive Function in the Elderly

Unknown
NCT04967404Not Applicable

The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists

Unknown
NCT02276716Phase 2

The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia

Completed
NCT02211560Not Applicable

Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

Terminated

All 6 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6